Related Experiment Video
Updated: Mar 28, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Potent Triazole Bisphosphonate Inhibitor of Geranylgeranyl Diphosphate Synthase
Veronica S Wills1, Cheryl Allen2, Sarah A Holstein2
1Department of Chemistry, University of Iowa , Iowa City, Iowa 52242-1294, United States.
Abstract:
Studies of triazole bisphosphonates have resulted in identification of a potent inhibitor of geranylgeranyl diphosphate synthase (IC50 = 45 nM) with very good selectivity for this enzyme over farnesyl diphosphate synthase (IC50 = 28 μM). This compound also potently disrupts geranylgeranylation and induces cytotoxicity in human myeloma cells at submicromolar levels, suggesting that it may serve as a lead compound for treatment of malignancies characterized by excessive protein secretion.
Related Concept Videos
Antifungal Agents
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Viral Protein Synthesis
Drugs that Stabilize Microtubules

